BRPI0407213A - Método de emprego da elevação de marinobufagenina na determinação da presença de pré-eclampsia e aparelhos relacionados - Google Patents
Método de emprego da elevação de marinobufagenina na determinação da presença de pré-eclampsia e aparelhos relacionadosInfo
- Publication number
- BRPI0407213A BRPI0407213A BR0407213-8A BRPI0407213A BRPI0407213A BR PI0407213 A BRPI0407213 A BR PI0407213A BR PI0407213 A BRPI0407213 A BR PI0407213A BR PI0407213 A BRPI0407213 A BR PI0407213A
- Authority
- BR
- Brazil
- Prior art keywords
- preeclampsia
- elevation
- determining
- marinobufagenin
- employing
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5302—Apparatus specially adapted for immunological test procedures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9453—Cardioregulators, e.g. antihypotensives, antiarrhythmics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"MéTODO DE EMPREGO DA ELEVAçãO DE MARINOBUFAGENINA NA DETERMINAçãO DA PRESENçA DE PRé-ECLAMPSIA E APARELHOS RELACIONADOS". é fornecido um método para determinação da presença de pré-eclampsia onde a determinação é feita baseada no fato de haver uma elevação substancial na marinobufagenina que pode ser derivada do sangue ou urina e se tal elevação não existe o que conclui que não existe pré-eclampsia na paciente. O método pode ser praticado vantajosamente pelo emprego de urina, soro sang³íneo, plasma sang³íneo como o espécime n corporal que contém a proteína na determinação de se a paciente tem pré-eclampsia. O método pode incluir subseq³ente tratamento terapêutico da paciente. Um aparelho diagnóstico relacionado também é fornecido.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44473003P | 2003-02-04 | 2003-02-04 | |
PCT/US2004/002802 WO2004071273A2 (en) | 2003-02-04 | 2004-02-02 | Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0407213A true BRPI0407213A (pt) | 2006-02-07 |
Family
ID=32869296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0407213-8A BRPI0407213A (pt) | 2003-02-04 | 2004-02-02 | Método de emprego da elevação de marinobufagenina na determinação da presença de pré-eclampsia e aparelhos relacionados |
Country Status (7)
Country | Link |
---|---|
US (1) | US7439071B2 (pt) |
EP (1) | EP1592967A4 (pt) |
JP (1) | JP4625800B2 (pt) |
AU (1) | AU2004210650C1 (pt) |
BR (1) | BRPI0407213A (pt) |
CA (1) | CA2515012A1 (pt) |
WO (1) | WO2004071273A2 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7402313B2 (en) | 2002-07-25 | 2008-07-22 | Charles David Adair | Method for controlling preeclampsia and eclampsia |
US7794716B2 (en) | 2002-07-25 | 2010-09-14 | Glenveigh Pharmaceuticals, Llc | Antibody composition and passive immunization against pregnancy-induced hypertension |
US7759329B2 (en) * | 2004-10-19 | 2010-07-20 | The Administrators Of The Tulane Educational Fund | Method of treating human preeclampsia employing resibufagenin |
WO2007002638A1 (en) * | 2005-06-27 | 2007-01-04 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Anti-marinobufagenin antibodies and methods for their use |
US20070257366A1 (en) * | 2006-05-03 | 2007-11-08 | Taiwan Semiconductor Manufacturing Company, Ltd. | Barrier layer for semiconductor interconnect structure |
US20080299602A1 (en) * | 2007-05-31 | 2008-12-04 | Puschett Jules B | Methods of Employing Vascular Leakage to Diagnose a Capillary Leak Disorder |
US20110044963A1 (en) * | 2009-03-09 | 2011-02-24 | Puschett Jules B | Method of Testing a Patient for Hypertension and Related Method of Treatment and Test Kit |
US20110008904A1 (en) * | 2009-07-10 | 2011-01-13 | Scott And White Memorial Hospital And Scott, Sherwood, And Brindley Foundation | Method for determining if a patient has a traumatic brain injury and related apparatus |
US20110207154A1 (en) * | 2010-01-12 | 2011-08-25 | Scott & White Healthcare | Method for determination of marinobufagenin levels and compounds employable in such method |
US20160299130A1 (en) * | 2015-04-09 | 2016-10-13 | Jules B. Puschett | Telocinobufagin (TCINO) in the Diagnosis and Pathogenesis of Preeclampsia, Traumatic Brain Injury and Acute Respiratory Distress Syndrome |
JP2021529215A (ja) * | 2018-06-21 | 2021-10-28 | シーティーエス・バイオファーマ・エルエルシー | 抗マリノブファゲニン抗体およびその使用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5079171A (en) | 1988-09-15 | 1992-01-07 | Adeza Biomedical Corporation | Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin |
JPH04505804A (ja) * | 1988-12-14 | 1992-10-08 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 子癇前症の検出のための診断的検定 |
GB9213934D0 (en) * | 1992-06-30 | 1992-08-12 | Smithkline Beecham Corp | Chemical compounds |
AU5728494A (en) * | 1992-12-02 | 1994-06-22 | Alexei Y. Bagrov | Anti-edlf antibody, composition thereof and method of diagnosing and treating cardiac arrhythmias, hypertension |
US5770376A (en) | 1992-12-02 | 1998-06-23 | Biomedical Sciences Research Laboratories, Inc. | Method of diagnosing and treating myocardial infarction and hypertension |
US5543138A (en) | 1994-03-10 | 1996-08-06 | Genetics Institute, Inc. | Methods of diagnosing and treating preeclampsia |
GB9618931D0 (en) * | 1996-09-11 | 1996-10-23 | Univ London | Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes |
US20030044856A1 (en) | 1997-09-26 | 2003-03-06 | Puschett Jules B. | Method of determining volume dependent hypertension through protein reduction in phosphorylation or concentration and related apparatus |
JPH11271222A (ja) * | 1998-03-24 | 1999-10-05 | Sekisui Chem Co Ltd | 尿検査方法 |
US7794716B2 (en) * | 2002-07-25 | 2010-09-14 | Glenveigh Pharmaceuticals, Llc | Antibody composition and passive immunization against pregnancy-induced hypertension |
US10167609B1 (en) | 2018-01-12 | 2019-01-01 | Cashman Dredging & Marine Contracting Co., LLC | Carouseling articulated dredge and barge |
-
2004
- 2004-02-02 WO PCT/US2004/002802 patent/WO2004071273A2/en active Application Filing
- 2004-02-02 BR BR0407213-8A patent/BRPI0407213A/pt not_active IP Right Cessation
- 2004-02-02 JP JP2006503224A patent/JP4625800B2/ja not_active Expired - Fee Related
- 2004-02-02 CA CA002515012A patent/CA2515012A1/en not_active Abandoned
- 2004-02-02 AU AU2004210650A patent/AU2004210650C1/en not_active Ceased
- 2004-02-02 US US10/544,468 patent/US7439071B2/en not_active Expired - Fee Related
- 2004-02-02 EP EP04707392A patent/EP1592967A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2515012A1 (en) | 2004-08-26 |
US20060263891A1 (en) | 2006-11-23 |
AU2004210650A1 (en) | 2004-08-26 |
US7439071B2 (en) | 2008-10-21 |
WO2004071273A3 (en) | 2005-02-03 |
EP1592967A4 (en) | 2007-06-20 |
WO2004071273A2 (en) | 2004-08-26 |
JP2006517670A (ja) | 2006-07-27 |
AU2004210650C1 (en) | 2010-01-14 |
EP1592967A2 (en) | 2005-11-09 |
AU2004210650B2 (en) | 2009-07-30 |
JP4625800B2 (ja) | 2011-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nekoofar et al. | pH of pus collected from periapical abscesses | |
EA200801071A1 (ru) | Способы и композиции для применения в целях лечения пациентов с положительным по аутоантителам заболеванием | |
CY1116107T1 (el) | Ενωσεις για χρηση στην αγωγη αυτοανοσων παθησεων, ανοσο-αλλεργικων παθησεων και απορριψης μεταμοσχευσης οργανων ή ιστων | |
ATE553378T1 (de) | Screening und behandlungsverfahren zur vorbeugung von frühgeburten | |
BRPI0407213A (pt) | Método de emprego da elevação de marinobufagenina na determinação da presença de pré-eclampsia e aparelhos relacionados | |
MX342791B (es) | Ensayo elisa para la detección de vegf. | |
DE60326214D1 (de) | Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten | |
BR112012008161B8 (pt) | dispositivo que pode ser usado no corpo do usuário para prover vácuo para usos clínicos | |
ES2249490T3 (es) | Articulos quirurgicos. | |
CY1107901T1 (el) | Μεθοδος προσδιορισμου για ασθενεια alzheimer | |
WO2007092427A3 (en) | Treatment of endotoxemia using endotoxin neutralizing agents | |
BRPI0518795A2 (pt) | mÉtodos para determinar a eficÁcia de um tratamento terapÊutico anti-inflamatàrio de um indivÍduo e para selecionar um indivÍduo que sofre de uma certa doenÇa inflamatària para receber tratamento terapÊutico anti-inflamatàrio | |
AU2001282364A1 (en) | Diagnosis and treatment of prostate cancer | |
EP1563308A4 (en) | METHOD AND KITS FOR TUMORIGENICITY DIAGNOSIS | |
EP1804789A4 (en) | METHOD FOR TREATING PREECLAMPSY IN HUMANS WITH RESIBUFAGENIN | |
ATE529750T1 (de) | Stimulatorische autoantikörper gegen den pdgf- rezeptor als pathologische marker und therapeutisches target | |
JP2006517670A5 (pt) | ||
BRPI0508053A (pt) | método de combater toxicidade causada por um composto antifolato, e de tratar uma doença, usos de enzima que possui atividade de carbóxi-peptidase g, de composto antifolato, de agente de resgate de rota de folato, e de enzima que possui atividade de carbóxi-peptidase g e de um agente de resgate de rota de folato, sistema terapêutico, e, método ex vivo de clivar um grupo l-glutamato terminal de um composto, de determinar a taxa e/ou extenção de clivagem de um composto, e de clivagem de um composto | |
Sanei et al. | Inflammatory cells’ role in acetic acid-induced colitis | |
CY1107921T1 (el) | Μεθοδος για την προγνωση της αθροιστικης επιβιωσης ασθενων | |
HUP0401953A2 (hu) | Biotinszármazékok | |
BR0113646A (pt) | Tratamento de distúrbios inflamatórios | |
WO2005030265A3 (en) | Optical imaging of endometriosis | |
Romão et al. | Impact of chronic pelvic pain on female sexual function | |
WO2006046108A3 (en) | Diagnosis of male infertility by measuring tissue factor pathway inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A, 5A, 6A, 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |